狂野欧美激情性xxxx欧美I 成人性生交大片免费看中文网站I 日韩视频一区二区在线I 国产中的精品av小宝探花I 黄色国产在线I 久久精品视频在线观看I 在线天堂8√

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購(gòu)物車 1 種商品 - 共0元
當(dāng)前位置: 首頁(yè) > ATCC代理 > pAVE2 [pAVE-2]
最近瀏覽歷史
聯(lián)系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮(zhèn)海區(qū)莊市街道興莊路9號(hào)
  • 創(chuàng)e慧谷42號(hào)樓B幢401室
pAVE2 [pAVE-2]
pAVE2 [pAVE-2]
規(guī)格:
貨期:
編號(hào):B199383
品牌:Mingzhoubio

標(biāo)準(zhǔn)菌株
定量菌液
DNA
RNA

規(guī)格:
凍干粉
斜面
甘油
平板


產(chǎn)品名稱 pAVE2 [pAVE-2]
商品貨號(hào) B199383
Designations pAVE2 [pAVE-2]
Depositors HA Barrera Saldana
Biosafety Level 1
Vector Information
Size (kb): 3.395
Vector: pAVE2 (plasmid)
Promoters: Promoter hCMV
Construction: pAVE1 (ATCC 37838), pMThGH
Marker(s):ampR
Construct size (kb): 3.395
Features: marker(s): ampR
promoter: hCMV
replicon: pMB1
terminator: hGH
enhancer: hCMV
Applications
expression vector
shuttle vector
Comments
Restriction digests of the clone give the following sizes (kb): HindIII-3.5; BamHI--3.5; EcoRI--3.5; SmaI--3.5.
Commercial use of the human cytomegalovirus promoter/enhancer has been patented on behalf of B. Fleckenstein and W. Schaffner by the Beringwerke. Interested parties should contact the patent holders before planning a commercial application.
A shuttle vector for transient expression of cDNA inserts in mammalian cells.
Constructed by inserting a 0.62 kb SmaI/EcoRI fragment from pMThGH containing part of exon 5 and 3' untranslated regions of the human growth hormone gene into the SmaI/EcoRI sites of pAVE1 (ATCC 37838).
Media ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
Growth Conditions
Temperature: 37.0°C
References

Ramirez-Solis R, et al. New vectors for the efficient expression of mammalian genes in cultured cells. Gene 87: 291-294, 1990. PubMed: 2158929

Shipped freeze-dried
梅經(jīng)理 17280875617 1438578920
胡經(jīng)理 13345964880 2438244627
周經(jīng)理 17757487661 1296385441
于經(jīng)理 18067160830 2088210172
沈經(jīng)理 19548299266 2662369050
李經(jīng)理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |